Data from Getting Personal with Melanoma

Autor: Helen Heslop
Rok vydání: 2023
DOI: 10.1158/1078-0432.c.6518440
Popis: Long-term follow-up of patients with metastatic melanoma who received adoptive immunotherapy with autologous tumor infiltrating lymphocytes shows that patients who attained complete remission had durable responses, with 19 of 20 such patients remaining in remission from 3 to 7 years or more. Clin Cancer Res; 17(13); 4189–91. ©2011 AACR.
Databáze: OpenAIRE